These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1430065)

  • 1. A novel, spectrophotometric microneutralization assay for respiratory syncytial virus.
    Rubino KL; Nicholas JA
    J Virol Methods; 1992 Sep; 39(1-2):55-67. PubMed ID: 1430065
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and application of a higher throughput RSV plaque assay by immunofluorescent imaging.
    Wen Z; Citron M; Bett AJ; Espeseth AS; Vora KA; Zhang L; DiStefano DJ
    J Virol Methods; 2019 Jan; 263():88-95. PubMed ID: 30381239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a simple, rapid, sensitive, high-throughput luciferase reporter based microneutralization test for measurement of virus neutralizing antibodies following Respiratory Syncytial Virus vaccination and infection.
    Fuentes S; Crim RL; Beeler J; Teng MN; Golding H; Khurana S
    Vaccine; 2013 Aug; 31(37):3987-94. PubMed ID: 23742994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of beta-galactosidase by recombinant respiratory syncytial viruses for microneutralization assay.
    Cheng X; Munoz MG; Zhou H; Jin H
    J Virol Methods; 2002 Sep; 105(2):287-96. PubMed ID: 12270661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a High-Throughput Respiratory Syncytial Virus Fluorescent Focus-Based Microneutralization Assay.
    Shambaugh C; Azshirvani S; Yu L; Pache J; Lambert SL; Zuo F; Esser MT
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an improved microneutralization assay for respiratory syncytial virus by automated plaque counting using imaging analysis.
    Zielinska E; Liu D; Wu HY; Quiroz J; Rappaport R; Yang DP
    Virol J; 2005 Nov; 2():84. PubMed ID: 16281972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin.
    Siber GR; Leombruno D; Leszczynski J; McIver J; Bodkin D; Gonin R; Thompson CM; Walsh EE; Piedra PA; Hemming VG
    J Infect Dis; 1994 Jun; 169(6):1368-73. PubMed ID: 8195619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and qualification of a fast, high-throughput and robust imaging-based neutralization assay for respiratory syncytial virus.
    Sun D; Hsu A; Bogardus L; Rubinstein LJ; Antonello JM; Gurney KB; Whiteman MC; Dellatore S
    J Immunol Methods; 2021 Jul; 494():113054. PubMed ID: 33845088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory Syncytial Virus (RSV): Neutralizing Antibody, a Correlate of Immune Protection.
    Piedra PA; Hause AM; Aideyan L
    Methods Mol Biol; 2016; 1442():77-91. PubMed ID: 27464689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats.
    Wyde PR; Moore DK; Hepburn T; Silverman CL; Porter TG; Gross M; Taylor G; Demuth SG; Dillon SB
    Pediatr Res; 1995 Oct; 38(4):543-50. PubMed ID: 8559607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay.
    Anderson LJ; Hierholzer JC; Bingham PG; Stone YO
    J Clin Microbiol; 1985 Dec; 22(6):1050-2. PubMed ID: 4066916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
    Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
    Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay.
    Siber GR; Leszcynski J; Pena-Cruz V; Ferren-Gardner C; Anderson R; Hemming VG; Walsh EE; Burns J; McIntosh K; Gonin R
    J Infect Dis; 1992 Mar; 165(3):456-63. PubMed ID: 1538152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model.
    Fuentes S; Klenow L; Golding H; Khurana S
    Sci Rep; 2017 Feb; 7():42428. PubMed ID: 28186208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An improved respiratory syncytial virus neutralization assay based on the detection of green fluorescent protein expression and automated plaque counting.
    van Remmerden Y; Xu F; van Eldik M; Heldens JG; Huisman W; Widjojoatmodjo MN
    Virol J; 2012 Oct; 9():253. PubMed ID: 23114196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic immunoprophylaxis of nasal respiratory syncytial virus infection in cotton rats.
    Sami IR; Piazza FM; Johnson SA; Darnell ME; Ottolini MG; Hemming VG; Prince GA
    J Infect Dis; 1995 Feb; 171(2):440-3. PubMed ID: 7844385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
    Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
    J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving ability of RSV microneutralization assay to detect G-specific and cross-reactive neutralizing antibodies through immortalized cell line selection.
    Boukhvalova MS; Mbaye A; Kovtun S; Yim KC; Konstantinova T; Getachew T; Khurana S; Falsey AR; Blanco JCG
    Vaccine; 2018 Jul; 36(31):4657-4662. PubMed ID: 29960801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study.
    McDonald JU; Rigsby P; Dougall T; Engelhardt OG;
    Vaccine; 2018 Nov; 36(50):7641-7649. PubMed ID: 30389194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.